Form D — KAZIA THERAPEUTICS LTD
0001470831-25-000435 · filed Dec 18, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $55,251,088
- Total sold
- $55,251,088
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- KAZIA THERAPEUTICS LTD
- CIK
- 1075880
- Entity
- Corporation
- Jurisdiction
- AUSTRALIA
- Year incorporated
- —
- Address
- THREE INTERNATIONAL TOWERS LEVEL 24,
SYDNEY NSW, C3 2000 - Phone
- 01161298780088
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Friend · Executive OfficerSydney, C3 Find on LinkedIn ↗
-
Bryce Carmine · DirectorSydney, C3 Find on LinkedIn ↗
-
Steven Coffey · DirectorSydney, C3 Find on LinkedIn ↗
-
Ebru Davidson · DirectorSydney, C3 Find on LinkedIn ↗
-
Robert Apple · DirectorSydney, C3 Find on LinkedIn ↗
-
Jeffrey Bonacorda · Executive OfficerSydney, C3 Find on LinkedIn ↗
-
Elissa Hansen · Executive OfficerSydney, C3 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗